BIOC
Closed
Biocept Inc
0.0698
+0.0388 (+125.16%)
Last Update: 26 Dec 2023 17:30:00
Yesterday: 0.031
Day's Range: 0.031 - 0.0698
Send
sign up or login to leave a comment!
When Written:
0.34
Biocept Inc is a publicly traded molecular diagnostics company based in San Diego, California. The company specializes in developing and commercializing liquid biopsy tests that detect cancer biomarkers in blood samples. These tests are designed to help clinicians diagnose and monitor cancer, as well as guide treatment decisions. Biocept's proprietary technology platform, called Target Selector, enables the detection and analysis of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) from a simple blood draw. The company's tests are used by oncologists, pathologists, and other healthcare professionals in the United States and internationally. Biocept was founded in 1997 and went public in 2014.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








